Cargando…
APY0201 Represses Tumor Growth through Inhibiting Autophagy in Gastric Cancer Cells
Gastric cancer (GC) is one of the most common cancers globally. There are currently few effective chemotherapeutic drugs available for GC patients. The inhibitors of phosphatidylinositol kinase containing an FYVE finger structure (PIKfyve) have shown significant anticancer effects in several types o...
Autores principales: | Li, Huan, Jin, Xinghan, Zhang, Shiwei, Li, Bo, Zeng, Leli, He, Yulong, Zhang, Changhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568353/ https://www.ncbi.nlm.nih.gov/pubmed/36245991 http://dx.doi.org/10.1155/2022/7104592 |
Ejemplares similares
-
Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer
por: Song, Shenglei, et al.
Publicado: (2021) -
Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer
por: Xu, Jiannan, et al.
Publicado: (2022) -
A thioredoxin reductase inhibitor ethaselen induces growth inhibition and apoptosis in gastric cancer
por: Wu, Wang, et al.
Publicado: (2020) -
Crosstalk of Histone and RNA Modifications Identified a Stromal-Activated Subtype with Poor Survival and Resistance to Immunotherapy in Gastric Cancer
por: Yuan, Cheng, et al.
Publicado: (2022) -
Comprehensive analysis to construct a novel immune-related prognostic panel in aging-related gastric cancer based on the lncRNA‒miRNA-mRNA ceRNA network
por: Deng, Cuncan, et al.
Publicado: (2023)